File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/00000658-200307000-00003
- Scopus: eid_2-s2.0-0042882883
- PMID: 12832961
- WOS: WOS:000185834900003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Clinical Significance of Angiogenesis in Gastrointestinal Cancers: A Target for Novel Prognostic and Therapeutic Approaches
Title | Clinical Significance of Angiogenesis in Gastrointestinal Cancers: A Target for Novel Prognostic and Therapeutic Approaches |
---|---|
Authors | |
Issue Date | 2003 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.annalsofsurgery.com |
Citation | Annals of Surgery, 2003, v. 238 n. 1, p. 9-28 How to Cite? |
Abstract | Objective: To review the current data on the prognostic and therapeutic implications of tumor angiogenesis in gastrointestinal cancers. Summary Background Data: Numerous studies have evaluated the prognostic value of tumor angiogenesis and the potential role of antiangiogenic therapy in various gastrointestinal cancers. Methods: A Medline literature search was conducted using "angiogenesis" or the names of various angiogenic factors in combination with the names of gastrointestinal cancers as the key words. Results: Several studies have demonstrated a significant prognostic impact of tumor microvessel density and tumor expression of angiogenic factors, in particular vascular endothelial growth factor (VEGF), in various gastrointestinal cancers. A few studies have suggested that circulating VEGF might be a useful prognostic marker. However, results were not consistent across all studies and were limited by the retrospective nature of most studies. Antiangiogenic therapy has been shown to be effective against all common gastrointestinal cancers in preclinical studies, but currently there are few clinical data with regard to antiangiogenic therapy in gastrointestinal cancers. Conclusions: There is mounting evidence to suggest that assessment of tumor angiogenesis might provide a novel approach of prognostication in patients with gastrointestinal cancers. However, current results from retrospective studies need to be validated by prospective studies. Antiangiogenic therapy is a promising strategy of cancer treatment that might be particularly useful in combination therapy for unresectable cancers or as an adjuvant therapy for resectable tumors. |
Persistent Identifier | http://hdl.handle.net/10722/49340 |
ISSN | 2023 Impact Factor: 7.5 2023 SCImago Journal Rankings: 2.729 |
PubMed Central ID | |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Poon, RTP | en_HK |
dc.contributor.author | Fan, ST | en_HK |
dc.contributor.author | Wong, J | en_HK |
dc.date.accessioned | 2008-06-12T06:39:52Z | - |
dc.date.available | 2008-06-12T06:39:52Z | - |
dc.date.issued | 2003 | en_HK |
dc.identifier.citation | Annals of Surgery, 2003, v. 238 n. 1, p. 9-28 | en_HK |
dc.identifier.issn | 0003-4932 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/49340 | - |
dc.description.abstract | Objective: To review the current data on the prognostic and therapeutic implications of tumor angiogenesis in gastrointestinal cancers. Summary Background Data: Numerous studies have evaluated the prognostic value of tumor angiogenesis and the potential role of antiangiogenic therapy in various gastrointestinal cancers. Methods: A Medline literature search was conducted using "angiogenesis" or the names of various angiogenic factors in combination with the names of gastrointestinal cancers as the key words. Results: Several studies have demonstrated a significant prognostic impact of tumor microvessel density and tumor expression of angiogenic factors, in particular vascular endothelial growth factor (VEGF), in various gastrointestinal cancers. A few studies have suggested that circulating VEGF might be a useful prognostic marker. However, results were not consistent across all studies and were limited by the retrospective nature of most studies. Antiangiogenic therapy has been shown to be effective against all common gastrointestinal cancers in preclinical studies, but currently there are few clinical data with regard to antiangiogenic therapy in gastrointestinal cancers. Conclusions: There is mounting evidence to suggest that assessment of tumor angiogenesis might provide a novel approach of prognostication in patients with gastrointestinal cancers. However, current results from retrospective studies need to be validated by prospective studies. Antiangiogenic therapy is a promising strategy of cancer treatment that might be particularly useful in combination therapy for unresectable cancers or as an adjuvant therapy for resectable tumors. | en_HK |
dc.format.extent | 388 bytes | - |
dc.format.mimetype | text/html | - |
dc.language | eng | en_HK |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.annalsofsurgery.com | en_HK |
dc.relation.ispartof | Annals of Surgery | en_HK |
dc.subject.mesh | Angiogenesis Inhibitors - therapeutic use | en_HK |
dc.subject.mesh | Endothelial Growth Factors - metabolism | en_HK |
dc.subject.mesh | Gastrointestinal Neoplasms - blood supply - drug therapy - metabolism | en_HK |
dc.subject.mesh | Intercellular Signaling Peptides and Proteins - metabolism | en_HK |
dc.subject.mesh | Lymphokines - metabolism | en_HK |
dc.title | Clinical Significance of Angiogenesis in Gastrointestinal Cancers: A Target for Novel Prognostic and Therapeutic Approaches | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Poon, RTP: poontp@hku.hk | en_HK |
dc.identifier.email | Fan, ST: stfan@hku.hk | en_HK |
dc.identifier.email | Wong, J: jwong@hkucc.hku.hk | en_HK |
dc.identifier.authority | Poon, RTP=rp00446 | en_HK |
dc.identifier.authority | Fan, ST=rp00355 | en_HK |
dc.identifier.authority | Wong, J=rp00322 | en_HK |
dc.description.nature | link_to_OA_fulltext | en_HK |
dc.identifier.doi | 10.1097/00000658-200307000-00003 | en_HK |
dc.identifier.pmid | 12832961 | en_HK |
dc.identifier.pmcid | PMC1422670 | en_HK |
dc.identifier.scopus | eid_2-s2.0-0042882883 | en_HK |
dc.identifier.hkuros | 83286 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0042882883&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 238 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 9 | en_HK |
dc.identifier.epage | 28 | en_HK |
dc.identifier.isi | WOS:000185834900003 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Poon, RTP=7103097223 | en_HK |
dc.identifier.scopusauthorid | Fan, ST=7402678224 | en_HK |
dc.identifier.scopusauthorid | Wong, J=8049324500 | en_HK |
dc.identifier.issnl | 0003-4932 | - |